The observations that BPM was associated with lower mortality rates than surveillance for BRCA1 and similar breast cancer-specific survival for BRCA2, underscore the importance of counseling BRCA1/2 mutation carriers on their choice between breast surveillance and BPM. The gene discussed is BRCA2; the disease is breast carcinoma.